About
Dr Yasser Ged is a medical oncologist dedicated to the care of patients with genitourinary malignancies. Their clinical and research focus is on the management of renal cell carcinoma (RCC). Dr Ged completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York.
Dr Ged has acted as site principal investigator (PI) for a number of clinical trials, including CONTACT-03, which investigated atezolizumab combined with cabozantinib versus cabozantinib alone after immune checkpoint therapy in patients with advanced kidney cancer. They are also the site PI for the natural history study, NCCAPS, which is investigating the effects of COVID-19 on cancer patients.
Dr Ged has acted as site principal investigator (PI) for a number of clinical trials, including CONTACT-03, which investigated atezolizumab combined with cabozantinib versus cabozantinib alone after immune checkpoint therapy in patients with advanced kidney cancer. They are also the site PI for the natural history study, NCCAPS, which is investigating the effects of COVID-19 on cancer patients.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Yasser Ged
Education & training
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncology
Career & appointments
-
2012-09–2013-08 Junior consultant
Licenses & insurance
Medical licenses
IE — Medical Council of Ireland
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 1,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,912 |
| Annual physical exam | 99395 | 2,094 |
| Vaccination administration | 90471 | 2,134 |
| Minor procedure (skin) | 17110 | 457 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 12 · i10: 9
-
Validation of clinical scoring in Oncology
DOI: 10.2186/euroclin.2026.0 · PMID: 32875197 · cited by 192
-
Long-term follow-up of Oncology across IE
DOI: 10.2105/euroclin.2025.1 · PMID: 31915380 · cited by 122
-
Validation of clinical scoring in Oncology
DOI: 10.2092/euroclin.2024.2 · PMID: 37834529 · cited by 100
-
Long-term follow-up of Oncology across IE
DOI: 10.2577/euroclin.2023.3 · PMID: 39342855 · cited by 190
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · Dublin · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — Dublin · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2013
- national college of family doctors — Member · Since 2013
- European Union of Medical Specialists (UEMS) — Member · Since 2013
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · yasser.ged@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
